298 related articles for article (PubMed ID: 15161824)
1. Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer.
Aijaz S; Erskine L; Jeffery G; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1667-73. PubMed ID: 15161824
[TBL] [Abstract][Full Text] [Related]
2. OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion cells and intrinsic neurons of the retina.
Pesch UE; Fries JE; Bette S; Kalbacher H; Wissinger B; Alexander C; Kohler K
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4217-25. PubMed ID: 15505078
[TBL] [Abstract][Full Text] [Related]
3. Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.
Corajevic N; Larsen M; Rönnbäck C
Acta Ophthalmol; 2018 May; 96(3):251-256. PubMed ID: 29091347
[TBL] [Abstract][Full Text] [Related]
4. SDOCT thickness measurements of various retinal layers in patients with autosomal dominant optic atrophy due to OPA1 mutations.
Schild AM; Ristau T; Fricke J; Neugebauer A; Kirchhof B; Sadda SR; Liakopoulos S
Biomed Res Int; 2013; 2013():121398. PubMed ID: 24024178
[TBL] [Abstract][Full Text] [Related]
5. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy.
Williams PA; Morgan JE; Votruba M
Brain; 2010 Oct; 133(10):2942-51. PubMed ID: 20817698
[TBL] [Abstract][Full Text] [Related]
6. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy.
Rönnbäck C; Nissen C; Almind GJ; Grønskov K; Milea D; Larsen M
Acta Ophthalmol; 2015 Dec; 93(8):762-6. PubMed ID: 26385429
[TBL] [Abstract][Full Text] [Related]
8. OPA1 expression in the normal rat retina and optic nerve.
Ju WK; Misaka T; Kushnareva Y; Nakagomi S; Agarwal N; Kubo Y; Lipton SA; Bossy-Wetzel E
J Comp Neurol; 2005 Jul; 488(1):1-10. PubMed ID: 15912498
[TBL] [Abstract][Full Text] [Related]
9. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.
Heiduschka P; Schnichels S; Fuhrmann N; Hofmeister S; Schraermeyer U; Wissinger B; Alavi MV
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1424-31. PubMed ID: 19834041
[TBL] [Abstract][Full Text] [Related]
11. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
12. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.
White KE; Davies VJ; Hogan VE; Piechota MJ; Nichols PP; Turnbull DM; Votruba M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2567-71. PubMed ID: 19234344
[TBL] [Abstract][Full Text] [Related]
13. Influence of Opa1 Mutation on Survival and Function of Retinal Ganglion Cells.
González-Menéndez I; Reinhard K; Tolivia J; Wissinger B; Münch TA
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4835-45. PubMed ID: 26218912
[TBL] [Abstract][Full Text] [Related]
14. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma.
Ju WK; Kim KY; Duong-Polk KX; Lindsey JD; Ellisman MH; Weinreb RN
Mol Vis; 2010 Jul; 16():1331-42. PubMed ID: 20664796
[TBL] [Abstract][Full Text] [Related]
15. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
16. OPA1 expression in the human retina and optic nerve.
Wang AG; Fann MJ; Yu HY; Yen MY
Exp Eye Res; 2006 Nov; 83(5):1171-8. PubMed ID: 16857190
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy.
Kalogerou M; Ioannou S; Kolovos P; Prokopiou E; Potamiti L; Kyriacou K; Panagiotidis M; Ioannou M; Fella E; Worth EP; Georgiou T
Exp Eye Res; 2022 Feb; 215():108901. PubMed ID: 34933001
[TBL] [Abstract][Full Text] [Related]
18. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.
Davies VJ; Hollins AJ; Piechota MJ; Yip W; Davies JR; White KE; Nicols PP; Boulton ME; Votruba M
Hum Mol Genet; 2007 Jun; 16(11):1307-18. PubMed ID: 17428816
[TBL] [Abstract][Full Text] [Related]
19. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function.
Lei Q; Xiang K; Cheng L; Xiang M
Stem Cell Reports; 2024 Jan; 19(1):68-83. PubMed ID: 38101398
[TBL] [Abstract][Full Text] [Related]
20. OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
